RxDoctor Payments Data

Jason Donnelly, MD

Pain Medicine · Lebanon, NHNPI 1487951299

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Abbott at 52.2% of the total.

$2,175in general payments, 2019–2025

Across 49 payments — averaging $44.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • SPR Therapeutics, Inc$211
  • Painteq LLC$170
  • Nevro Corp.$146
  • Globus Medical$117
  • Medtronic$76
  • plus $321 from 10 others

What the payments were for

  • Food & beverage$2,175100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,175 in reported general payments places this provider in the 55th percentile of 38 pain medicine providers in New Hampshire.

See all pain medicine providers in New Hampshire

Medicare billing

Part B allowed, 2024
$105,002
Medicare patients
238
Services billed
1,250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine13$1,736
Gabapentin66$1,422
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen34$888
Tizanidine Hcl22$627
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$262
Methylprednisolone43$261
Meloxicam56$219
Cyclobenzaprine Hcl25$157
Tramadol Hcl16$89
Diazepam21$12

Paid to pharmacies, not to this prescriber.

Other pain medicine in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →